proscar 100 preis ashwagandha rasayana kaufen alternative orthotropics baclofen 500 mg levaquin 500 mg price evista 10 mg nizoral kaufen maxalt 10 preis erythromycin 500mg price tetracycline salbe kaufen alternative januvia fosamax preisvergleich depo medrol alternative omnicef alternatives viadrene plus the herbal viagra alternative penegra 100 nebenwirkungen nexium mups ohne rezept benzac 10 percent atacand kaufen alternative zu bupropion penegra 100 side effects fosamax preisvergleich inderal 40 kaufen capoten 50 mg tab alternative zu micardis alternative for glycomet actonel 35 mg kaufen cefadroxil 500 mg cost acivir 200 dt used for lamisil tabletten ohne rezept kaufen alternative to flagyl for c diff lipitor alternatives high cholesterol prandina guru s3 preis tamoxifen generika flagyl ohne rezept kaufen aricept 10 mg side effects benzac 10 percent hyzaar 50 125 efectos secundarios xalatan 50 mcgml trazodone 150 mg high benzac 10 percent erythromycin 500mg price requip modutab 8 mg preisvergleich l- tryptophan 250 plus bonusan femara 10 year study adalat june 14 2015 levitra ersatz priligy dapoxetine kaufen lisinopril 20 mg h147 augmentin 250 mg5ml casodex 150 mg januvia drug alternatives casodex 150 mg preis toprol xl 50mg nolvadex alternative metformin preisliste urispas 200 dosage generika dutasterid pravachol 10 alternative norvasc terramycin 100 dosage finasterid 1mg kaufen methotrexate 10 mg and alcohol what is trimox 500 mg 8020 reglan anafranil 50mg side effects keflex alternative allergy amitriptyline 10mg i1 ersatz für ciprofloxacin metoclopramide 10 mg espanol kamagra gold preis citalopram 30 mg preis pulmicort 200 mcg turbuhaler adaalat 7th may 2015 lisinopril 10 mg alternative amoxicillin allergy what is ciplox 500mg used for ciprofloxacin 500 dan urispas 200 bemo allegra preis augmentin 250 mg tablets strattera ohne rezept hyzaar 50 125 efectos secundarios what is ciplox 500mg used for tamoxifen 10mg vs 20mg eurax 10 cream l- tryptophan 250 plus bonusan chloramphenicol kaufen apotheke adler ortho kaufen aleve 200 any otc alternatives to flonase keflex 2505ml tulasi 50 days centers Creepy vs. Donor-Centered - Collins Group
Skagit Valley Hospital

Creepy vs. Donor-Centered



About a week ago, the Wall Street Journal published an article entitled “Smart Money: Is Your Favorite Charity Spying on You?

The article describes how nonprofits research donors by using wealth screening tools, public records and databases that provide career and education information, stock holdings, charitable giving history, campaign contributions, and home and real estate values. Researchers have been mining this data for years; it’s nothing new. What’s new is how the internet and software tools have made the practice quicker, easier, and more comprehensive.

To those of us in the profession, we understand that this (publically available and legally-obtained) information is just one part of the equation that will help us understand our organization’s best donors and prospects. This information is balanced with a donor’s affinity for our organization and work, their giving history to us, and their connections to our staff and volunteer leaders. Together, this helps development staff focus their efforts, and make the best use of time and money, in order to advance their missions and create positive change for their communities.

Last week I attended the Willamette Valley Development Officers regional conference and heard Portland State University staff describe a program to connect with donors and alumni. Initial phone calls placed by a recent alum help PSU learn about their donors’ interests and experiences and their communication preferences so that staff can best engage with them in the areas they care about. This program is successful in identifying donors who are interested in learning more about PSU, its schools, and future plans, and those who are not – all of which is important information for their development staff. Their program is respectful, responsive, donor-centered – and research-based.

How do we avoid being creepy? By following the ethical standards set by the Association for Fundraising Professionals and the Association of Prospect Researchers for Advancement, and by developing donor confidentiality and prospect research policies for our organizations to ensure that information is used judiciously and respectfully. Also, by not saying creepy things to donors (or anyone for that matter) such as “when I was googling you the other day, I saw that…”

As far as the special treatment we bestow upon those we see as future major donors, a question brought up in the WSJ article in reference to hospitals and medical institutions, that is one each organization must reconcile for itself. Are you donor-centered or creepy? What would your donors say?


Like this post? Why not share it?


About the Author

Natalie Lamberjack

Natalie Lamberjack CFRE

Senior Consultant

Natalie dials into the needs of her clients by keeping a calm eye on the big picture view of the nonprofit sector.


Leave a Reply